MedTrace Logo

Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors

NCT02400827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2015-03-27

No results posted yet for this study

Summary

For prepubertal patients, cryopreservation of ovarian tissue is the only option available to preserve their fertility before cancer treatment. But ovarian autograft raises the issue of the risk of reintroduction of potentially malignant cells. The aim of our study is to develop a specific and sensitive method for residual disease detection in the ovarian tissue from patients treated for a solid tumor during infancy, whose fertility may have been compromised by treatments and who benefited of ovarian tissue cryopreservation.

Conditions

  • Minimal Residual Disease
  • Fertility Preservation

Interventions

OTHER

malignant cells

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Justyna KANOLD · University Hospital, Clermont-Ferrand

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-11-30
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02400827 on ClinicalTrials.gov